Bioscrip has announced a life sciences IPO for common stock worth $75million.
Posted on 18 April 2013
Bioscrip has announced a life sciences IPO for common stock worth $75million.
Posted on 17 April 2013
Auris Medical secures $50.6 Million in Series C financing deal.
Posted on 28 January 2013
Anthera Pharmaceuticals announced the pricing of an underwritten pharma IPO of 60,606,061 shares of its common stock, offered at a price of $0.66 per share
Posted on 02 March 2012
Horizon Pharma announced the execution of a securities purchase agreement with a select group of institutional and accredited investors providing for a private placement financing.